SpliceBio Raises €130M Series B to Advance Stargardt Gene Therapy and Expand Genetic Medicines
SpliceBio has raised €130M in Series B funding to advance its gene therapy for Stargardt disease and expand its pipeline using a proprietary protein splicing platform.